SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001047469-20-001756
Filing Date
2020-03-25
Accepted
2020-03-25 08:22:46
Documents
4
Period of Report
2020-05-12

Document Format Files

Seq Description Document Type Size
1 PRE 14A a2241128zpre14a.htm PRE 14A 623818
2 G1031066.JPG g1031066.jpg GRAPHIC 40568
3 G21662BII001.JPG g21662bii001.jpg GRAPHIC 103840
4 G21662BII002.JPG g21662bii002.jpg GRAPHIC 93108
  Complete submission text file 0001047469-20-001756.txt   952462
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-31918 | Film No.: 20740023
SIC: 2836 Biological Products, (No Diagnostic Substances)